Significance of prophylactic hyperthermic intraperitoneal chemotherapy after curative resection of gastrointestinal cancers
Horvath P, Yurttas C, Beckert S, Struller F, Königsrainer A, Königsrainer I (2021)
Publication Type: Authored book
Publication year: 2021
Publisher: Springer International Publishing
ISBN: 9783030626402
DOI: 10.1007/978-3-030-62640-2_17
Abstract
Peritoneal metastases originating from gastrointestinal cancers are still the most powerful negative prognostic factor. Despite initial curative resection, a significant proportion of patients develop peritoneal recurrence. Additional hyperthermic intraperitoneal chemotherapy after curative resection might have the ability to reduce the incidence of local and peritoneal recurrences without significant elevation of morbidity and mortality rates.
Involved external institutions
Universitätsklinikum Tübingen
Germany (DE)
Schwarzwald-Baar Klinikum
Germany (DE)
Landeskrankenhaus Feldkirch
Austria (AT)
Germany (DE)
Schwarzwald-Baar Klinikum
Germany (DE)
Landeskrankenhaus Feldkirch
Austria (AT)
How to cite
APA:
Horvath, P., Yurttas, C., Beckert, S., Struller, F., Königsrainer, A., & Königsrainer, I. (2021). Significance of prophylactic hyperthermic intraperitoneal chemotherapy after curative resection of gastrointestinal cancers. Springer International Publishing.
MLA:
Horvath, Philipp, et al. Significance of prophylactic hyperthermic intraperitoneal chemotherapy after curative resection of gastrointestinal cancers. Springer International Publishing, 2021.
BibTeX: Download